These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 21303577)

  • 1. The pressure wire as a diagnostic tool in patients with congenital cardiac disease.
    Hamid T; Hadi H; Clarke B; Mahadevan V
    Cardiol Young; 2011 Jun; 21(3):317-20. PubMed ID: 21303577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications.
    Dimopoulos K; Giannakoulas G; Wort SJ; Gatzoulis MA
    Curr Opin Cardiol; 2008 Nov; 23(6):545-54. PubMed ID: 18830068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy.
    D'Alto M; Romeo E; Argiento P; Santoro G; Sarubbi B; Gaio G; Mélot C; Russo MG; Naeije R; Calabrò R
    Heart; 2010 Sep; 96(18):1475-9. PubMed ID: 20668108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bosentan induces clinical and hemodynamic improvement in candidates for right-sided heart bypass surgery.
    Hirono K; Yoshimura N; Taguchi M; Watanabe K; Nakamura T; Ichida F; Miyawaki T
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):346-51. PubMed ID: 20434177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bosentan on exercise capacity and quality of life in adults with pulmonary arterial hypertension associated with congenital heart disease with and without Down's syndrome.
    Duffels MG; Vis JC; van Loon RL; Nieuwkerk PT; van Dijk AP; Hoendermis ES; de Bruin-Bon RH; Bouma BJ; Bresser P; Berger RM; Mulder BJ
    Am J Cardiol; 2009 May; 103(9):1309-15. PubMed ID: 19406277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful application of a PressureWire retrogradely across an ATS prosthetic aortic valve to diagnose constrictive pericarditis.
    Palmer S; Mariani JA; Newcomb A; Stokes MB; Burns AT
    Cardiovasc Revasc Med; 2012; 13(5):289-91. PubMed ID: 22634335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Percutaneous catheter-based implantation of artificial pulmonary valves in patients with congenital heart defects].
    Wyller VB; Aaberge L; Thaulow E; Døhlen G
    Tidsskr Nor Laegeforen; 2011 Jul; 131(13-14):1289-93. PubMed ID: 21725388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease.
    Durongpisitkul K; Jakrapanichakul D; Sompradikul S
    J Med Assoc Thai; 2008 Feb; 91(2):196-202. PubMed ID: 18389984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-the-wire-technique device implantation.
    Butera G; Castaldi B; Macdonald ST
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):485-92. PubMed ID: 22511555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease.
    Diller GP; Dimopoulos K; Kaya MG; Harries C; Uebing A; Li W; Koltsida E; Gibbs JS; Gatzoulis MA
    Heart; 2007 Aug; 93(8):974-6. PubMed ID: 17639112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis.
    Cam A; Goel SS; Agarwal S; Menon V; Svensson LG; Tuzcu EM; Kapadia SR
    J Thorac Cardiovasc Surg; 2011 Oct; 142(4):800-8. PubMed ID: 21320709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined endothelin receptor antagonist and transcatheter interventional therapy of patent ductus arteriosus with severe pulmonary artery hypertension.
    Ussia GP; Mulè M; Caruso E; Aiello R; Tamburino C
    Int J Cardiol; 2007 Apr; 116(3):427-9. PubMed ID: 16875749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative pulmonary hemodynamics and assessment of operability: is there a pulmonary vascular resistance that precludes cardiac operation?
    Giglia TM; Humpl T
    Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S57-69. PubMed ID: 20216166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can "inoperable" congenital heart defects become operable in patients with pulmonary arterial hypertension? Dream or reality?
    Beghetti M; Galiè N; Bonnet D
    Congenit Heart Dis; 2012; 7(1):3-11. PubMed ID: 22233186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a wire control catheter to treat complex pulmonary artery or vein anatomy.
    Manica JL; Piazza L; Butera G
    J Invasive Cardiol; 2012 Jul; 24(7):E148-52. PubMed ID: 22781486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy.
    Dimopoulos K; Peset A; Gatzoulis MA
    Int J Cardiol; 2008 Sep; 129(2):163-71. PubMed ID: 18367267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult congenital heart disease and pulmonary hypertension: management of a complex case.
    Daniels CJ
    Eur Respir Rev; 2012 Dec; 21(126):362-4. PubMed ID: 23204125
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?
    van Loon RL; Hoendermis ES; Duffels MG; Vonk-Noordegraaf A; Mulder BJ; Hillege HL; Berger RM
    Am Heart J; 2007 Oct; 154(4):776-82. PubMed ID: 17893008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical aortic valve replacement in children and adolescents after previous repair of congenital heart disease.
    Popov AF; Coskun KO; Tirilomis T; Schmitto JD; Hinz J; Kriebel T; Schoendube FA; Ruschewski W
    Artif Organs; 2009 Nov; 33(11):915-21. PubMed ID: 19817736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.